Related Experiment Video
Updated: Jul 11, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
Published on: August 19, 2015
Bioengineered carbohydrate polymers for colon-specific drug release: Current trends and future prospects
Darshan Bhirud1, Sankha Bhattacharya1, Bhupendra G Prajapati2
1Department of Pharmaceutics, School of Pharmacy & Technology Management, SVKM's NMIMS Deemed-to-be University, Shirpur, Maharashtra, India.
Bioengineered carbohydrate polymers offer a promising solution for targeted colorectal cancer drug delivery, enhancing treatment efficacy and reducing side effects. These advanced materials enable precise medication release in the colon, improving patient outcomes.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Colorectal cancer (CRC) presents a significant global health challenge, with conventional chemotherapy often causing systemic toxicity due to poor drug selectivity.
- Bioengineered carbohydrate polymers are emerging as effective carriers for colon-specific drug delivery, aiming to improve therapeutic outcomes and minimize adverse effects.
Purpose of the Study:
- To provide a comprehensive overview of current advancements and future prospects in bioengineered carbohydrate polymer synthesis for colon-specific drug delivery in colorectal cancer therapy.
- To explore various strategies for achieving targeted drug release in the colon and enhancing tumor selectivity.
Main Methods:
- Review of colon-targeted drug release techniques, including enzyme-sensitive, pH-responsive, and microbiota-activated polymers.
- Investigation of active targeting strategies, such as ligand conjugation, to improve tumor selectivity and cellular uptake.
- Examination of biomimetic approaches like protein corona engineering and cell membrane coating for enhanced nanocarrier performance.
Main Results:
- Bioengineered carbohydrate polymers demonstrate tunable properties for colon-specific delivery, utilizing natural polymers like hyaluronic acid, chitosan, alginate, and pectin.
- Integration of active targeting and combination therapy strategies shows potential for improved efficacy and overcoming drug resistance.
- Biomimetic advances and intelligent systems offer enhanced biocompatibility, cellular uptake, and tumor penetration for nanocarriers.
Conclusions:
- Bioengineered carbohydrate polymers represent a significant advancement in colon-specific drug delivery for colorectal cancer, offering improved therapeutic potential.
- Future directions include the development of sophisticated, responsive systems for precise and regulated drug distribution, ultimately aiming to improve patient care.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
06:34Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Overview
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Drug Delivery Systems: Delayed-Release Systems